Telomere length varies by DNA extraction method: Implications for epidemiologic research

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 11, 2013, Pages 2047-2054

  Cunningham, Julie M ^a   Johnson, Ruth A ^a   Litzelman, Kristin ^e   Skinner, Halcyon G ^e   Seo, Songwon ^f   Engelman, Corinne D ^e   Vanderboom, Russell J ^d   Kimmel, Grace W ^g   Gangnon, Ronald E ^f   Riegert Johnson, Douglas L ^h   Baron, John A ⁱ   Potter, John D ^j   Haile, Robert ^k   Buchanan, Daniel D ^l   Jenkins, Mark A ^m   Rider, David N ^c   Thibodeau, Stephen N ^a   Petersen, Gloria M ^b   Boardman, Lisa A ^c  

^a Departments of Laboratory Medicine and Pathology   (United States)

^b Departments of Health Sciences Research   (United States)

^c Mayo Clinic   (United States)

^d MAYO CLINIC CANCER CENTER   (United States)

^e Departments of Population Health Sciences   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

^h MAYO CLINIC   (United States)

ⁱ DARTMOUTH MEDICAL SCHOOL   (United States)

^j Fred Hutchinson Cancer Research Center   (United States)

^k STANFORD CANCER INSTITUTE   (United States)

^l QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^m UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROFORM; DNA; PHENOL;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TELOMERE; TELOMERE HOMEOSTASIS;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA; DNA, NEOPLASM; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; TELOMERE;

EID: 84887300926     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0409     Document Type: Article

References (48)

1. Aviv A. Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J Mol Med 2002;80:689-95.
2. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005;26:1263-71.
3. McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007;16:815-9.
4. Wu G, Jiang X, Lee WH, Chen PL. Assembly of functional ALTassociated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1. Cancer Res 2003;63:2589-95.
5. Gramatges MM, Telli ML, Balise R, Ford JM. Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev 2010;19:605-13.
6. Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN, et al. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res 2010;70:3170-6.
7. Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM. Short telomere length and breast cancer risk: A study in sister sets. Cancer Res 2007;67:5538-44.
8. Svenson U, Nordfjall K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, et al. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res 2008;68:3618-23.
9. Levy T, Agoulnik I, Atkinson EN, Tong XW, Gause HM, Hasenburg A, et al. Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients. Anticancer Res 1998; 18:1345-9.
10. Martinez P, Blasco MA. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 2011;11: 161-76.
11. Jones AM, Beggs AD, Carvajal-Carmona L, Farrington S, Tenesa A, Walker M, et al. TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut 2012;61:248-54.
12. Cui Y, Cai Q, Qu S, Chow WH, Wen W, Xiang YB, et al. Association of leukocyte telomere length with colorectal cancer risk: nested case- control findings from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev 2012;21:1807-13.
13. Risques RA, Vaughan TL, Li X, Odze RD, Blount PL, Ayub K, et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007;16:2649-55.
14. Hou L, Savage SA, Blaser MJ, Perez-Perez G, Hoxha M, Dioni L, et al. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev 2009;18:3103-9.
15. Liu X, Bao G, Huo T, Wang Z, He X, Dong G. Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population. Cancer Sci 2009;100:1300-5.
16. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstatter A, et al. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010;304:69-75.
17. Jang JS, Choi YY, Lee WK, Choi JE, Cha SI, Kim YJ, et al. Telomere length and the risk of lung cancer. Cancer Sci 2008;99:1385-9.
18. Widmann TA, Herrmann M, Taha N, Konig J, Pfreundschuh M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp Hematol 2007;35:939-46.
19. Mirabello L, Richards EG, Duong LM, Yu K, Wang Z, Cawthon R, et al. Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet 2011;2:19-29.
20. Mirabello L, Yu K, Kraft P, De Vivo I, Hunter DJ, Prescott J, et al. The association of telomere length and genetic variation in telomere biology genes. Hum Mutat 2010;31:1050-8.
21. Skinner HG, Gangnon RE, Litzelman K, Johnson RA, Chari ST, Petersen GM, et al. Telomere length and pancreatic cancer: A case-control study. Cancer Epidemiol Biomarkers Prev 2012;21:2095-100.
22. Shao L, Wood CG, Zhang D, Tannir NM, Matin S, Dinney CP, et al. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol 2007;178:1492-6.
23. Han J, Qureshi AA, Prescott J, Guo Q, Ye L, Hunter DJ, et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol 2009;129:415-21.
24. Nan H, Qureshi AA, Prescott J, De Vivo I, Han J. Genetic variants in telomere-maintaining genes and skin cancer risk. Hum Genet 2011; 129:247-53.
25. Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA. The association of telomere length and cancer: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2011;20:1238-50.
26. Aviv A, Hunt SC, Lin J, Cao X, Kimura M, Blackburn E. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by southern blots and qPCR. Nucleic Acids Res 2011; 39:e134.
27. Olsen MT, Berube M, Robbins J, Palsboll PJ. Empirical evaluation of humpback whale telomere length estimates; quality control and factors causing variability in the singleplex and multiplex qPCR methods. BMC Genet 2012;13:77.
28. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp P. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 1998;16:743.
29. Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, et al. Colon Cancer Family Registry: An international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2331-43.
30. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002;30:e47.
31. Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning AM, et al. Shortened telomere length is associated with increased risk of cancer: A metaanalysis. PLoS ONE 2011;6:e20466.
32. Martinez-Delgado B, Yanowsky K, Inglada-Perez L, de la Hoya M, Caldes T, Vega A, et al. Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases. J Med Genet 2012;49:341-4.
33. Odagiri E, Kanada N, Jibiki K, Demura R, Aikawa E, Demura H. Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer 1994;73:2978-84.
34. Mirabello L, Garcia-Closas M, Cawthon R, Lissowska J, Brinton LA, Peplonska B, et al. Leukocyte telomere length in a population-based case-control study of ovarian cancer: A pilot study. Cancer Causes Control 2010;21:77-82.
35. Kunifuji Y, Gotoh S, Abe T, Miura M, Karasaki Y. Downregulation of telomerase activity by anticancer drugs in human ovarian cancer cells. Anticancer Drugs 2002;13:595-8.
36. Alter BP, Rosenberg PS, Giri N, Baerlocher GM, Lansdorp PM, Savage SA. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica 2012;97:353-9.
37. Agrawal A, Dang S, Gabrani R. Recent patents on anti-telomerase cancer therapy. Recent Pat Anticancer Drug Discov 2012;7:102-17.
38. Butlin R, Debelle A, Kerth C, Snook RR, Beukeboom LW, Castillo Cajas RF, et al. What do we need to know about speciation? Trends Ecol Evol 2012;27:27-39.
39. De Vivo I, Prescott J, Wong JY, Kraft P, Hankinson SE, Hunter DJ. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2009;18: 1152-6.
40. Martinez-Delgado B, Yanowsky K, Inglada-Perez L, Domingo S, Urioste M, Osorio A, et al. Genetic anticipation is associated with telomere shortening in hereditary breast cancer. PLoS Genet 2011;7: e1002182.
41. Jones CH, Pepper C, Baird DM. Telomere dysfunction and its role in haematological cancer. Br J Haematol 2012;156:573-87.
42. Zee RY, Castonguay AJ, Barton NS, Buring JE. Mean telomere length and risk of incident colorectal carcinoma: A prospective, nested case-control approach. Cancer Epidemiol Biomarkers Prev 2009;18:2280-2.
43. Prescott J, McGrath M, Lee IM, Buring JE, De Vivo I. Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer 2010;116:4275-82.
44. Xing J, Ajani JA, Chen M, Izzo J, Lin J, Chen Z, et al. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res 2009;2:459-65.
45. Hosgood HD III, Cawthon R, He X, Chanock S, Lan Q. Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. Lung Cancer 2009;66:157-61.
46. Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding D, Crawford ED, et al. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell 2009;8:405-13.
47. Hofmann JN, Baccarelli A, Schwartz K, Davis FG, Ruterbusch JJ, Hoxha M, et al. Risk of renal cell carcinoma in relation to blood telomere length a population-cased case-control study. Br J Cancer 2011;105: 1772-5.
48. Liang G, Qureshi AA, Guo Q, De Vivo I, Han J. No association between telomere length in peripheral blood leukocytes and the risk of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 2011; 20:1043-5.